跳至主要内容
临床试验/NCT07121114
NCT07121114已完成不适用

CAPTIVATE India - A Cross-Sectional Study to Assess the Prevalence of Cardiovascular Disease (CVD) in Individuals With Type 2 Diabetes Mellitus (T2DM) in India.

Novo Nordisk A/S1 个研究点 分布在 1 个国家目标入组 1,500 人开始时间: 2025年4月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,500
试验地点
1
主要终点
Proportion of individuals with established Cardio Vascular Disease (CVD)

研究概览

简要总结

This is a cross-sectional study assessing the prevalence of Cardiovascular Disease and describing cardio-renal risk factors among individuals with Type 2 Diabetes Mellitus in India based on medical records.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female individuals with type 2 diabetes mellitus (T2DM), aged above or equal to 18 years.
  • A confirmed diagnosis of T2DM before ethical clearance at every participating institution.
  • Medical records available between 01 January 2024 to 30 September 2024 ought to have the data points required for the primary and secondary objectives. Medical records must have at least 6 months (greater than or equal to 180 days) of follow-up data from the date of diagnosis.

排除标准

  • Diagnosis of Type 1 diabetes, or maturity-onset diabetes of the young (MODY).
  • Known congenital heart disease or malformation.

结局指标

主要结局

Proportion of individuals with established Cardio Vascular Disease (CVD)

时间窗: From start of data collection to end of data collection (approximately 3 months)

Proportion

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验